drugset / Trial / NCT01967264

Safety and Pharmacokinetic Profile of Udenafil in Healthy Mexican Adults

NCT01967264

Phase 1 Completed 83 enrolled Takeda
RandomizedCrossoverQuadruple-blind

Summary

The purpose of this study is to evaluate the safety and tolerability of Udenafil 150 mg compared to placebo.

Timeline

Start
2013-07
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Udenafil Small molecule 150 mg Oral

Indications